Craneware plc with ticker (LON:CRW) now has a potential upside of 33.4% according to Shore Capital.
Shore Capital set a target price of 2,300 GBX for the company, which when compared to the Craneware plc share price of 1,533 GBX at opening today (07/03/2023) indicates a potential upside of 33.4%. Trading has ranged between 1,340 (52 week low) and 2,250 (52 week high) with an average of 144,945 shares exchanging hands daily. The market capitalisation at the time of writing is £537,911,185.
Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture and Pricing, Claims Analytics, Revenue Recovery and Retention, and Cost and Margin Analytics. The Company’s solutions include Chargemaster Toolkit, Trisus Supply, Physician Revenue Toolkit, Reference Plus, Integration for Chargemaster Management, Pharmacy ChargeLink, Trisus Pricing Analyzer, Online Reference Toolkit, Trisus Supplies Assistant, InSight Medical Necessity, Trisus Claims Informatics, InSight Audit, Trisus Healthcare Intelligence, Trisus Pricing Transparency, InSight Denials, Appeals Service, and Customer Success Management and Consulting Services. It has approximately 2,000 United States hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies.